Maury Raycroft
Stock Analyst at Jefferies
(4.39)
# 1,226
Out of 4,444 analysts
220
Total ratings
43%
Success rate
11.2%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Maintained: Buy | $132 | $90.80 | +45.37% | 6 | Jun 15, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $39 | $28.68 | +35.98% | 2 | Jun 8, 2026 | |
| TNGX Tango Therapeutics | Downgraded: Hold | $19 → $27 | $29.12 | -7.28% | 2 | May 14, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $53 → $33 | $8.18 | +303.67% | 7 | May 12, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 | $3.96 | +203.03% | 1 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $8 → $9 | $2.02 | +345.54% | 4 | Apr 27, 2026 | |
| ERAS Erasca | Maintained: Buy | $6 → $21 | $15.05 | +39.53% | 2 | Apr 13, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $14 → $52 | $36.28 | +43.33% | 2 | Apr 5, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $39 → $56 | $36.00 | +55.56% | 4 | Mar 26, 2026 | |
| VALN Valneva SE | Maintained: Buy | $14 → $15 | $5.23 | +186.81% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $1.75 | +1,500.00% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $5.03 | +297.61% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $18.62 | +12.78% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.49 | +7.38% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $549 | $294.06 | +86.70% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $10.00 | +50.00% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $33.90 | +20.94% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $57.69 | -39.33% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $79 | $96.38 | -18.03% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $23 | $9.43 | +143.90% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $1.26 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $6.94 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $3.12 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $15 | $9.25 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3042 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.20 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $31 | $30.37 | n/a | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $129 | $29.11 | n/a | 14 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $0.0001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $26.01 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.16 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $39.51 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $79.81 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $53.55 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $1.65 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $109 | $15.50 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $25 | $10.55 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $86 | $18.37 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $35 | $9.12 | n/a | 6 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $6.74 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $1.86 | n/a | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $55.58 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.62 | n/a | 2 | May 22, 2018 |
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $132
Current: $90.80
Upside: +45.37%
Hemab Therapeutics Holdings
Jun 8, 2026
Maintained: Buy
Price Target: $39
Current: $28.68
Upside: +35.98%
Tango Therapeutics
May 14, 2026
Downgraded: Hold
Price Target: $19 → $27
Current: $29.12
Upside: -7.28%
Corbus Pharmaceuticals Holdings
May 12, 2026
Maintained: Buy
Price Target: $53 → $33
Current: $8.18
Upside: +303.67%
Bicycle Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $12
Current: $3.96
Upside: +203.03%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $2.02
Upside: +345.54%
Erasca
Apr 13, 2026
Maintained: Buy
Price Target: $6 → $21
Current: $15.05
Upside: +39.53%
IDEAYA Biosciences
Apr 5, 2026
Maintained: Buy
Price Target: $14 → $52
Current: $36.28
Upside: +43.33%
Kodiak Sciences
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $36.00
Upside: +55.56%
Valneva SE
Mar 23, 2026
Maintained: Buy
Price Target: $14 → $15
Current: $5.23
Upside: +186.81%
Feb 25, 2026
Maintained: Buy
Price Target: $28
Current: $1.75
Upside: +1,500.00%
Dec 8, 2025
Maintained: Buy
Price Target: $15 → $20
Current: $5.03
Upside: +297.61%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $18.62
Upside: +12.78%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.49
Upside: +7.38%
Oct 30, 2025
Maintained: Buy
Price Target: $384 → $549
Current: $294.06
Upside: +86.70%
Oct 14, 2025
Maintained: Buy
Price Target: $14 → $15
Current: $10.00
Upside: +50.00%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $33.90
Upside: +20.94%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $57.69
Upside: -39.33%
Aug 15, 2025
Maintained: Buy
Price Target: $33 → $79
Current: $96.38
Upside: -18.03%
Aug 13, 2025
Maintained: Buy
Price Target: $40 → $23
Current: $9.43
Upside: +143.90%
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $1.26
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $8
Current: $6.94
Upside: n/a
May 19, 2025
Maintained: Buy
Price Target: $15 → $9
Current: $3.12
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $7 → $15
Current: $9.25
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3042
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $21
Current: $1.20
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $25 → $31
Current: $30.37
Upside: n/a
Oct 4, 2024
Rated: Buy
Price Target: $129
Current: $29.11
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $10 → $20
Current: $0.0001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $26.01
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $1.16
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $39.51
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $75
Current: $79.81
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $53.55
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $1.65
Upside: n/a
Jun 22, 2021
Maintained: Buy
Price Target: $37 → $109
Current: $15.50
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $14 → $25
Current: $10.55
Upside: n/a
Jul 29, 2020
Maintained: Buy
Price Target: $34 → $86
Current: $18.37
Upside: n/a
Jun 23, 2020
Maintained: Buy
Price Target: $34 → $35
Current: $9.12
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $25
Current: $6.74
Upside: n/a
Feb 24, 2020
Initiated Coverage: Buy
Price Target: $47
Current: $1.86
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $55.58
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $5.62
Upside: n/a